Form 4: IQVIA Director Acquires 211 Deferred Shares

IQVIA Holdings Inc. Director Jim Fasano acquired 211 deferred shares, convertible into common stock, as part of a pre-arranged plan.

Summary

• Jim Fasano, a Director at IQVIA Holdings Inc. (IQV), acquired 211 deferred shares.
• The transaction occurred on February 9, 2026, and was filed on February 11, 2026.
• Each deferred share is convertible into one share of IQVIA Holdings Inc. common stock upon settlement.
• The deferred shares become settleable when the reporting person ceases to be a director, upon a change in control of the company, or upon the death of the reporting person.
• The underlying common stock was valued at $192.67 per share at the time of deferral.
• Following this acquisition, Jim Fasano beneficially owns a total of 4,274 deferred shares.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged purchase or sale plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. It's a routine compensation-related acquisition by a director, which generally indicates continued alignment with shareholder interests, but does not suggest significant new information about the company's operational or financial performance.

Positives

• A director's acquisition of shares, even if compensation-related, generally signals continued alignment with shareholder interests and confidence in the company's future.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding the company's future performance, beyond the settlement conditions for the deferred shares.

Industry Context

StockSavvy.ai notes that insider transactions, such as this acquisition of deferred shares by a director, are routine disclosures in the life sciences and healthcare technology industry. While this specific transaction is small, it reflects ongoing compensation practices for non-employee directors, aligning their interests with long-term shareholder value, a common practice among peers like Veeva Systems or Medidata Solutions.

Comparison to Industry Standards

• The use of deferred shares as part of non-employee director compensation is a standard practice across many industries, including healthcare technology, aligning director incentives with long-term company performance.
• The disclosure via Form 4 is a standard regulatory requirement for insider transactions, consistent with practices observed in comparable companies.

Corporate Governance

Stakeholder Impact

• Shareholders: The acquisition of deferred shares by a director can be seen as a positive signal of confidence in the company's future, potentially reinforcing investor sentiment.
• Employees: No direct impact mentioned.

Next Steps

• The deferred shares will become settleable upon Jim Fasano ceasing to be a director, a change in control of IQVIA Holdings Inc., or his death.

Key Dates

Keywords

IQVIA, IQV, Jim Fasano, Director, Insider Transaction, Form 4, Deferred Shares, Common Stock, Share Acquisition, 10b5-1 Plan